HomeBusinessHealthcare Industry Stock NewsBiotech’s Next Gold Rush: Weight-Loss Drugs

Biotech’s Next Gold Rush: Weight-Loss Drugs

Biotech’s next gold rush is weight-loss drugs. There is a dominance of NVO and LLY in this space for now, notes Rahul Jasuja. He discusses which stocks will benefit from weight-loss drugs. He also talks about the function of Visible Alpha’s GLP-1 monitor. Tune in to find out more about the stock market today.

The Watch List

02 Apr 2024

SHARE

ON AIR
2:00 pm
Market On Close
12:00 am
Fast Market
REPLAY
1:00 am
Next Gen Investing
REPLAY
2:00 am
Gamma On
REPLAY
3:00 am
Gamma On
REPLAY
3:30 am
Gamma On
REPLAY
4:00 am
Gamma On
REPLAY
4:30 am
Gamma On
REPLAY
5:30 am
Gamma On
REPLAY
6:00 am
Market Overtime
REPLAY
6:30 am
Market Overtime
REPLAY
7:00 am
Futures
8:00 am
Morning Trade Live
10:00 am
Trading 360
11:00 am
Fast Market
12:00 pm
Next Gen Investing
1:00 pm
The Watch List
ON AIR
2:00 pm
Market On Close
3:30 pm
Gamma On
REPLAY
4:00 pm
Gamma On
REPLAY
5:00 pm
Gamma On
REPLAY
6:00 pm
Gamma On
REPLAY
7:00 pm
Gamma On
REPLAY
7:30 pm
Market Overtime
REPLAY
8:00 pm
Market Overtime
REPLAY
8:30 pm
Market Overtime
REPLAY
9:00 pm
Gamma On
REPLAY
9:30 pm
Market Overtime
REPLAY
education
10:00 pm
Inside the Mind of a Trader
REPLAY
education
10:30 pm
Inside the Mind of a Trader
REPLAY
education
11:00 pm
Inside the Mind of a Trader
REPLAY
education
11:30 pm
Your First Trade
REPLAY

Get the Market Minute

Daily insights for every investor